Vimarsana
Biggest News Aggregation in the World

Page 30 - Accessed March News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed March Today - Breaking & Trending Today

How one woman's rare type of ovarian cancer was almost overlooked | Senior Living - Vimarsana News

How one woman's rare type of ovarian cancer was almost overlooked | Senior Living

(BPT) - Richmond, Virginia, resident Tiffany Stout never realized that in the prime of her life she would not only be battling cancer, but also a cancer that is rare

Oral positive expiratory pressure device may aid in COPD breathlessness, desaturation - Vimarsana News

Oral positive expiratory pressure device may aid in COPD breathlessness, desaturation

Patients with COPD who experience breathlessness and exertional desaturation may see improvements with use of an oral positive expiratory device, according to study results published in Respiratory Care.“PEP buddy is an adjunct to current COPD therapies, such as inhalers and pulmonary rehabilitation,” Muhammad Ahsan Zafar, MD, co-creator of the device and associate professor in the

Source: healio.com
Weight Regain May Not Completely Mitigate Benefits of Behavior Management Programs - Vimarsana News

Weight Regain May Not Completely Mitigate Benefits of Behavior Management Programs

A systematic review and meta-analysis of more than 120 randomized trials offers new insight into the effects of weight regain on cardiometabolic risk up to 5 years after the cessation of a behavioral management program.

Poly and NuCurrent Partner to Power Pro-Grade Devices Enabling Work from Anywhere - Vimarsana News

Poly and NuCurrent Partner to Power Pro-Grade Devices Enabling Work from Anywhere

/PRNewswire/ -- Today at Enterprise Connect, Poly, an HP company and global provider of professional-grade audio and video solutions, and NuCurrent, the global...

Delivery Matters: In Early Studies, DPX Technology Allows Vaccines to Persist When Cancer Pushes Back - Vimarsana News

Delivery Matters: In Early Studies, DPX Technology Allows Vaccines to Persist When Cancer Pushes Back

Based on promising results, the biotech IMV has moved into phase 2b trials with a cancer vaccine composed of survivin epitopes that uses the company’s proprietary delivery system to elicit persistent immune responses.

Source: ajmc.com